Document is current

Any future updates will be listed below

Serine peptidase inhibitor Kazal type 1 (SPINK1) as novel downstream effector of the cadherin-17/β-catenin axis in hepatocellular carcinoma

Crossref DOI link: https://doi.org/10.1007/s13402-017-0332-x

Published Online: 2017-06-19

Published Print: 2017-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark